MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)
V118_18
Phase 3 mab completed
Quick answer
MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV) for Influenza is a Phase 3 program (mab) at Seqirus (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Seqirus (Australia) Pty Ltd
- Indication
- Influenza
- Phase
- Phase 3
- Modality
- mab
- Status
- completed